Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B1 | P14061 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | CYP19A1 | P11511 | 4/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1087793 | 1.00 | HSD17B1 (0.32) | HSD17B1MEN1POLBKMT2ACYP19A1 | |
| SCHEMBL7733048 | 1.00 | HSD17B1 (0.32) | HSD17B1MEN1POLBKMT2ACYP19A1 | |
| SCHEMBL7733030 | 1.00 | HSD17B1 (0.32) | HSD17B1MEN1POLBKMT2ACYP19A1 | |
| SCHEMBL7737030 | 0.86 | MEN1 (0.38) | MEN1POLBKMT2ACYP19A1 | |
| SCHEMBL7735247 | 0.83 | MEN1 (0.39) | HSD17B1MEN1POLBKMT2ACYP19A1 | |
| SCHEMBL7733008 | 0.82 | MEN1 (0.39) | MEN1POLBKMT2ACYP19A1 | |
| SCHEMBL7733024 | 0.82 | MEN1 (0.39) | MEN1POLBKMT2ACYP19A1 | |
| SCHEMBL7734509 | 0.81 | ACE (0.33) | MEN1POLBKMT2A | |
| SCHEMBL7733945 | 0.81 | — | — | |
| SCHEMBL7734459 | 0.81 | HSD17B3 (0.40) | MEN1POLBKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6407284-B1 | CONTACTING WITH ENZYME; HYDROLYSIS | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2002-06-18 | — | — | US | disclosed |
| EP-0776201-B1 | Treating anxiety | LILLY CO ELI (US) | 2001-10-17 | — | — | EP | disclosed |
| EP-0776200-A4 | COMPOSITION AND METHOD FOR PROTECTION AGAINST DRUG DEPENDENCY | LILLY CO ELI (US) | 2001-01-17 | — | — | EP | disclosed |
| EP-0776201-A4 | COMPOSITION AND METHOD FOR TREATING ANXIETY | LILLY CO ELI (US) | 1999-07-07 | — | — | EP | disclosed |
| US-5661184-A | ADMINISTERING AN AGONIST TO TREAT BENZODIAZEPINE DRUG ABUSE, DRUG DEPENDENCE | ELI LILLY AND COMPANY (US) | 1997-08-26 | — | — | US | disclosed |
| EP-0776200-A1 | COMPOSITION AND METHOD FOR PROTECTION AGAINST DRUG DEPENDENCY | ELI LILLY AND COMPANY (US) | 1997-06-04 | — | — | EP | disclosed |
| EP-0776201-A1 | COMPOSITION AND METHOD FOR TREATING ANXIETY | ELI LILLY AND COMPANY (US) | 1997-06-04 | — | — | EP | disclosed |
| EP-0774454-A1 | Excitatory amino acid receptor antagonists | ELI LILLY AND COMPANY (US) | 1997-05-21 | — | — | EP | disclosed |
| WO-1996004901-A1 | COMPOSITION AND METHOD FOR TREATING ANXIETY | ELI LILLY AND COMPANY (US) | 1996-02-22 | — | — | WO | disclosed |
| WO-1996004900-A1 | COMPOSITION AND METHOD FOR PROTECTION AGAINST DRUG DEPENDENCY | ELI LILLY AND COMPANY (US) | 1996-02-22 | — | — | WO | disclosed |